\-\ Texto\\:\\ \ \(0\)\
\-\ radiographically\\,\\ the\\ lungs\\ have\\ a\\ characteristic\\ pattern\\ consisting\\ of\\ fine\\ reticular\\ granularity\\ of\\ the\\ parenchyma\\ and\\ air\\ bronchograms\\ that\\ are\\ often\\ more\\ prominent\\ early\\ in\\ the\\ left\\ lower\\ lobe\\ because\\ of\\ superimposition\\ of\\ the\\ cardiac\\ shadow\\.\\ occasionally\\,\\ the\\ initial\\ cxr\\ is\\ normal\\ and\\ develops\\ into\\ the\\ typical\\ pattern\\ by\\ 6\\-12\\ hours\\ of\\ life\\.\\ there\\ can\\ be\\ considerable\ \(0\)\
\-\ ion\\ among\\ films\\ due\\ to\\ phase\\ of\\ respiration\\ and\\ use\\ of\\ cpap\\.\\ this\\ case\\ illustrates\\ how\\ medical\\ management\\ with\\ close\\ radiographic\\ follow\\ up\\ can\\ drastically\\ improve\\ the\\ hmd\\ related\\ morbidity\\ and\\ mortality\\.\ \(0\)\
\-\ hyaline\\ membrane\\ disease\ \(2\)\
\-\ patient\\ is\\ a\\ 1123\\ g\\ caucasian\\ infant\\ male\\ born\\ at\\ 29\\+0\\ weeks\\ gestation\\ via\\ low\\ transverse\\ c\\-section\\ due\\ to\\ maternal\\ pre\\-eclampsia\\ and\\ abnormal\\ non\\-reassuring\\ fetal\\ heart\\ tracings\\.\\ upon\\ delivery\\ the\\ patient\\ was\\ noted\\ to\\ have\\ respiratory\\ distress\\ with\\ grunting\\ and\\ retractions\\.\\ he\\ was\\ intubated\\,\\ given\\ one\\ dose\\ of\\ survanta\\,\\ and\\ started\\ on\\ a\\ rule\\-out\\ sepsis\\ protocol\\ with\\ cbc\\,\\ blood\\ cultures\\,\\ and\\ started\\ on\\ ampicillin\\ and\\ gentamycin\\.\\ the\\ patient\\'s\\ chest\\ x\\-ray\\ showed\\ ground\\ glass\\ opacity\\ consistent\\ with\\ hyaline\\ membrane\\ disease\\.\\ the\\ patient\\ did\\ not\\ improve\\ with\\ surfactant\\.\\ he\\ was\\ then\\ placed\\ on\\ a\\ high\\ frequency\\ oscillator\\ ventilator\\ with\\ slight\\ improvement\\.\\ the\\ patient\\ was\\ then\\ given\\ another\\ dose\\ of\\ surfactant\\ and\\ kept\\ on\\ the\\ oscillator\\.\\ over\\ the\\ next\\ several\\ hours\\ the\\ patient\\'s\\ lung\\ opacity\\ markedly\\ improved\\.\ \(0\)\
\-\ hyaline\\ membrane\\ disease\\ is\\ a\\ major\\ cause\\ of\\ death\\ in\\ the\\ newborn\\ period\\.\\ approximately\\ 50\\%\\ of\\ all\\ neonatal\\ deaths\\ are\\ due\\ to\\ hmd\\ or\\ its\\ complications\\.\\ the\\ lungs\\ are\\ poorly\\ compliant\\ due\\ to\\ a\\ deficiency\\ of\\ surfactant\\ which\\ results\\ in\\ progressive\\ atelectasis\\,\ \(0\)\
\-\ intra\\-pulmonary\\ shunting\\,\\ hypoxemia\\,\\ and\\ cyanosis\\.\\ the\\ hyaline\\ membrane\\ that\\ forms\\ and\\ lines\\ the\\ alveoli\\ is\\ composed\\ of\\ protein\\ and\\ sloughed\\ epithelium\\.\\ this\\ is\\ the\\ result\\ of\\ oxygen\\ exposure\\,\\ alveolar\\ capillary\\ leakage\\,\\ and\\ the\\ forces\\ generated\\ by\\ mechanical\\ ventilation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hyaline\\:\\ 0\\.2860107976877594\ \(0\)\
\-\ membrane\\:\\ 0\\.24312578869626855\ \(0\)\
\-\ surfactant\\:\\ 0\\.2320317245459506\ \(0\)\
\-\ the\\:\\ 0\\.2311100976096329\ \(0\)\
\-\ hmd\\:\\ 0\\.17699446783435174\ \(0\)\
\-\ oscillator\\:\\ 0\\.17699446783435174\ \(0\)\
\-\ and\\:\\ 0\\.16753473671456268\ \(0\)\
\-\ of\\:\\ 0\\.15866319350282931\ \(0\)\
\-\ due\\:\\ 0\\.13315517827550494\ \(0\)\
\-\ patient\\:\\ 0\\.11301483094671055\ \(0\)\
\-\ improve\\:\\ 0\\.11246602601832456\ \(0\)\
\-\ dose\\:\\ 0\\.10816209955255916\ \(0\)\
\-\ opacity\\:\\ 0\\.10078360849823716\ \(0\)\
\-\ started\\:\\ 0\\.09756323023914329\ \(0\)\
\-\ granularity\\:\\ 0\\.09261359459476111\ \(0\)\
\-\ ion\\:\\ 0\\.09261359459476111\ \(0\)\
\-\ 1123\\:\\ 0\\.09261359459476111\ \(0\)\
\-\ tracings\\:\\ 0\\.09261359459476111\ \(0\)\
\-\ survanta\\:\\ 0\\.09261359459476111\ \(0\)\
\-\ drastically\\:\\ 0\\.08849723391717587\ \(0\)\
\-\ gentamycin\\:\\ 0\\.08849723391717587\ \(0\)\
\-\ hours\\:\\ 0\\.08827549812287463\ \(0\)\
\-\ pattern\\:\\ 0\\.08647311971676598\ \(0\)\
\-\ hypoxemia\\:\\ 0\\.08557662953715402\ \(0\)\
\-\ lungs\\:\\ 0\\.08547873246758761\ \(0\)\
\-\ sloughed\\:\\ 0\\.08331123278236964\ \(0\)\
\-\ then\\:\\ 0\\.08198941796974377\ \(0\)\
\-\ superimposition\\:\\ 0\\.08146026885956878\ \(0\)\
\-\ was\\:\\ 0\\.08073135914155748\ \(0\)\
\-\ ampicillin\\:\\ 0\\.07989530116154757\ \(0\)\
\-\ deaths\\:\\ 0\\.07989530116154757\ \(0\)\
\-\ compliant\\:\\ 0\\.07989530116154757\ \(0\)\
\-\ given\\:\\ 0\\.07967488229983669\ \(0\)\
\-\ is\\:\\ 0\\.07929771564915417\ \(0\)\
\-\ grunting\\:\\ 0\\.07734390818198354\ \(0\)\
\-\ alveoli\\:\\ 0\\.07734390818198354\ \(0\)\
\-\ generated\\:\\ 0\\.07734390818198354\ \(0\)\
\-\ respiration\\:\\ 0\\.07627426772476255\ \(0\)\
\-\ cpap\\:\\ 0\\.07530666023283641\ \(0\)\
\-\ disease\\:\\ 0\\.07292796385158651\ \(0\)\
\-\ to\\:\\ 0\\.07238919603806837\ \(0\)\
\-\ ventilator\\:\\ 0\\.07088722646422217\ \(0\)\
\-\ kept\\:\\ 0\\.07030694312437645\ \(0\)\
\-\ on\\:\\ 0\\.0699614448825069\ \(0\)\
\-\ bronchograms\\:\\ 0\\.06975804217301791\ \(0\)\
\-\ leakage\\:\\ 0\\.06975804217301791\ \(0\)\
\-\ considerable\\:\\ 0\\.06874197542635524\ \(0\)\
\-\ he\\:\\ 0\\.06858650434474785\ \(0\)\
\-\ with\\:\\ 0\\.06803914059563139\ \(0\)\
\-\ retractions\\:\\ 0\\.06781841223167423\ \(0\)\
\-\ forces\\:\\ 0\\.06697190591237107\ \(0\)\
\-\ epithelium\\:\\ 0\\.06657372960042081\ \(0\)\
\-\ reticular\\:\\ 0\\.06619058244679123\ \(0\)\
\-\ are\\:\\ 0\\.06592469635661968\ \(0\)\
\-\ shunting\\:\\ 0\\.06512094198957022\ \(0\)\
\-\ consisting\\:\\ 0\\.06446573436433276\ \(0\)\
\-\ maternal\\:\\ 0\\.06326997806676937\ \(0\)\
\-\ sepsis\\:\\ 0\\.06326997806676937\ \(0\)\
\-\ composed\\:\\ 0\\.06299181834920363\ \(0\)\
\-\ develops\\:\\ 0\\.06245736892283557\ \(0\)\
\-\ illustrates\\:\\ 0\\.06245736892283557\ \(0\)\
\-\ morbidity\\:\\ 0\\.062200337609548365\ \(0\)\
\-\ ventilation\\:\\ 0\\.061949653401557926\ \(0\)\
\-\ among\\:\\ 0\\.061232730117622224\ \(0\)\
\-\ how\\:\\ 0\\.061232730117622224\ \(0\)\
\-\ intubated\\:\\ 0\\.061232730117622224\ \(0\)\
\-\ neonatal\\:\\ 0\\.061232730117622224\ \(0\)\
\-\ alveolar\\:\\ 0\\.06078144717406714\ \(0\)\
\-\ capillary\\:\\ 0\\.06078144717406714\ \(0\)\
\-\ can\\:\\ 0\\.06078056840207618\ \(0\)\
\-\ forms\\:\\ 0\\.06034937368674751\ \(0\)\
\-\ cyanosis\\:\\ 0\\.06014004267072693\ \(0\)\
\-\ oxygen\\:\\ 0\\.059536764542813723\ \(0\)\
\-\ shadow\\:\\ 0\\.05915361738918413\ \(0\)\
\-\ fine\\:\\ 0\\.05896733336283783\ \(0\)\
\-\ glass\\:\\ 0\\.058254606067633705\ \(0\)\
\-\ have\\:\\ 0\\.05786025315128259\ \(0\)\
\-\ radiographically\\:\\ 0\\.0577510882700427\ \(0\)\
\-\ lines\\:\\ 0\\.0577510882700427\ \(0\)\
\-\ gestation\\:\\ 0\\.057428769306725656\ \(0\)\
\-\ mechanical\\:\\ 0\\.057428769306725656\ \(0\)\
\-\ newborn\\:\\ 0\\.057116369440036986\ \(0\)\
\-\ mortality\\:\\ 0\\.05696370198278877\ \(0\)\
\-\ death\\:\\ 0\\.05681329634900799\ \(0\)\
\-\ deficiency\\:\\ 0\\.056665086496481894\ \(0\)\
\-\ protocol\\:\\ 0\\.05651900923394191\ \(0\)\
\-\ ground\\:\\ 0\\.0563750040592939\ \(0\)\
\-\ occasionally\\:\\ 0\\.05555140174201577\ \(0\)\
\-\ born\\:\\ 0\\.055291074796629654\ \(0\)\
\-\ frequency\\:\\ 0\\.05503725671159889\ \(0\)\
\-\ exposure\\:\\ 0\\.05503725671159889\ \(0\)\
\-\ cultures\\:\\ 0\\.0545478995942236\ \(0\)\
\-\ delivery\\:\\ 0\\.05442915912259754\ \(0\)\
\-\ next\\:\\ 0\\.05408104977627958\ \(0\)\
\-\ fetal\\:\\ 0\\.053744482116460046\ \(0\)\
\-\ protein\\:\\ 0\\.053744482116460046\ \(0\)\
\-\ close\\:\\ 0\\.052402648556356665\ \(0\)\
\-\ poorly\\:\\ 0\\.05230641850324696\ \(0\)\
\-\ atelectasis\\:\\ 0\\.0515677513802185\ \(0\)\
\-\ caucasian\\:\\ 0\\.051479085361675656\ \(0\)\
\-\ improved\\:\\ 0\\.05139118702392197\ \(0\)\
\-\ infant\\:\\ 0\\.05113196797340153\ \(0\)\
\-\ markedly\\:\\ 0\\.05113196797340153\ \(0\)\
\-\ slight\\:\\ 0\\.05071412321243561\ \(0\)\
\-\ major\\:\\ 0\\.05063257904237249\ \(0\)\
\-\ period\\:\\ 0\\.05063257904237249\ \(0\)\
\-\ improvement\\:\\ 0\\.05055168463355582\ \(0\)\
\-\ that\\:\\ 0\\.05026310912418958\ \(0\)\
\-\ phase\\:\\ 0\\.049554820076448944\ \(0\)\
\-\ by\\:\\ 0\\.049185428096064396\ \(0\)\
\-\ cbc\\:\\ 0\\.04831856833392215\ \(0\)\
\-\ life\\:\\ 0\\.047510934536616506\ \(0\)\
\-\ another\\:\\ 0\\.04739219406499045\ \(0\)\
\-\ via\\:\\ 0\\.047333340598189236\ \(0\)\
\-\ parenchyma\\:\\ 0\\.04704408471867249\ \(0\)\
\-\ characteristic\\:\\ 0\\.04681847110960018\ \(0\)\
\-\ distress\\:\\ 0\\.046652491479205055\ \(0\)\
\-\ cxr\\:\\ 0\\.046328457762975984\ \(0\)\
\-\ respiratory\\:\\ 0\\.046066112555512746\ \(0\)\
\-\ films\\:\\ 0\\.04586101073954979\ \(0\)\
\-\ prominent\\:\\ 0\\.04561032653155936\ \(0\)\
\-\ upon\\:\\ 0\\.04556092402730141\ \(0\)\
\-\ placed\\:\\ 0\\.04512679731020606\ \(0\)\
\-\ results\\:\\ 0\\.04512679731020606\ \(0\)\
\-\ typical\\:\\ 0\\.04475589963873836\ \(0\)\
\-\ transverse\\:\\ 0\\.04462023354961846\ \(0\)\
\-\ complications\\:\\ 0\\.04435422196631489\ \(0\)\
\-\ progressive\\:\\ 0\\.04435422196631489\ \(0\)\
\-\ use\\:\\ 0\\.044310556545918214\ \(0\)\
\-\ related\\:\\ 0\\.04401004681674895\ \(0\)\
\-\ result\\:\\ 0\\.043354839191511486\ \(0\)\
\-\ in\\:\\ 0\\.0432197379390553\ \(0\)\
\-\ cardiac\\:\\ 0\\.043004056690855476\ \(0\)\
\-\ radiographic\\:\\ 0\\.04296581862459018\ \(0\)\
\-\ its\\:\\ 0\\.04285196104326647\ \(0\)\
\-\ management\\:\\ 0\\.04277675925798836\ \(0\)\
\-\ early\\:\\ 0\\.04174465006196455\ \(0\)\
\-\ did\\:\\ 0\\.041543609936230415\ \(0\)\
\-\ because\\:\\ 0\\.040473969479009414\ \(0\)\
\-\ 50\\:\\ 0\\.04044415390811799\ \(0\)\
\-\ heart\\:\\ 0\\.04026707625735558\ \(0\)\
\-\ this\\:\\ 0\\.0397990829195991\ \(0\)\
\-\ cause\\:\\ 0\\.0394522168209175\ \(0\)\
\-\ initial\\:\\ 0\\.03884945794700495\ \(0\)\
\-\ showed\\:\\ 0\\.03857336147395227\ \(0\)\
\-\ several\\:\\ 0\\.037995829779222064\ \(0\)\
\-\ air\\:\\ 0\\.03787953761884794\ \(0\)\
\-\ often\\:\\ 0\\.03778745358987432\ \(0\)\
\-\ approximately\\:\\ 0\\.036951953354863336\ \(0\)\
\-\ medical\\:\\ 0\\.03680527306927119\ \(0\)\
\-\ lung\\:\\ 0\\.03522842451021993\ \(0\)\
\-\ abnormal\\:\\ 0\\.03479264110340296\ \(0\)\
\-\ weeks\\:\\ 0\\.03470768500435746\ \(0\)\
\-\ all\\:\\ 0\\.034473521865255506\ \(0\)\
\-\ blood\\:\\ 0\\.03363296971844218\ \(0\)\
\-\ lobe\\:\\ 0\\.03346690781442613\ \(0\)\
\-\ low\\:\\ 0\\.03323011119974849\ \(0\)\
\-\ one\\:\\ 0\\.033157230810725885\ \(0\)\
\-\ high\\:\\ 0\\.0329132794149768\ \(0\)\
\-\ over\\:\\ 0\\.03220151345631915\ \(0\)\
\-\ more\\:\\ 0\\.03179977880559274\ \(0\)\
\-\ consistent\\:\\ 0\\.031401113808254465\ \(0\)\
\-\ follow\\:\\ 0\\.031219495465747024\ \(0\)\
\-\ into\\:\\ 0\\.0307849222382844\ \(0\)\
\-\ noted\\:\\ 0\\.030704757848673922\ \(0\)\
\-\ chest\\:\\ 0\\.030568788924419037\ \(0\)\
\-\ lower\\:\\ 0\\.029592999127321776\ \(0\)\
\-\ case\\:\\ 0\\.029094264538078257\ \(0\)\
\-\ up\\:\\ 0\\.02864679112786327\ \(0\)\
\-\ which\\:\\ 0\\.02633307704603905\ \(0\)\
\-\ male\\:\\ 0\\.025784566406077562\ \(0\)\
\-\ normal\\:\\ 0\\.023645004465917097\ \(0\)\
\-\ be\\:\\ 0\\.023492506881494134\ \(0\)\
\-\ there\\:\\ 0\\.023042930209618367\ \(0\)\
\-\ not\\:\\ 0\\.0228622057429285\ \(0\)\
\-\ at\\:\\ 0\\.021874024482034866\ \(0\)\
\-\ or\\:\\ 0\\.020146488144670842\ \(0\)\
\-\ left\\:\\ 0\\.01975498208068098\ \(0\)\
